Dr. Webb has 14 years of drug discovery and development experience in the industrial and academic settings, with a focus on the conduct and management of translational preclinical studies supporting the entry of novel drugs into clinical trials. This expertise includes an extensive background vivo pharmacodynamics, pharmacokinetic studies, ADME/biodistribution studies, non-GLP and GLP toxicology studies, drug combination studies and natural products. The focus of this expertise is in oncology, but also includes additional experience in microbial diseases. Dr. Webb also has expertise in the regulatory requirements for novel oncology in clinical testing and has initiated and managed Phase I cancer clinical trials. Collectively, Dr. Webb has more than 75 published research articles, including 24 patents (7 granted) and is the inventor of novel 6 drugs in advanced preclinical and clinical testing by 3 different US-based companies.